Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

BCAA metabolism in pancreatic cancer affects lipid balance by regulating fatty acid import into mitochondria

K. Gotvaldová, J. Špačková, J. Novotný, K. Baslarová, P. Ježek, L. Rossmeislová, J. Gojda, K. Smolková

. 2024 ; 12 (1) : 10. [pub] 20240326

Status neindexováno Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24005540

Grantová podpora
NV19-01-00101 Agentura Pro Zdravotnický Výzkum České Republiky
NV19-01-00101 Agentura Pro Zdravotnický Výzkum České Republiky
NV19-01-00101 Agentura Pro Zdravotnický Výzkum České Republiky

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has been associated with the host dysmetabolism of branched-chain amino acids (BCAAs), however, the implications for the role of BCAA metabolism in PDAC development or progression are not clear. The mitochondrial catabolism of valine, leucine, and isoleucine is a multistep process leading to the production of short-chain R-CoA species. They can be subsequently exported from mitochondria as short-chain carnitines (SC-CARs), utilized in anabolic pathways, or released from the cells. METHODS: We examined the specificities of BCAA catabolism and cellular adaptation strategies to BCAA starvation in PDAC cells in vitro. We used metabolomics and lipidomics to quantify major metabolic changes in response to BCAA withdrawal. Using confocal microscopy and flow cytometry we quantified the fluorescence of BODIPY probe and the level of lipid droplets (LDs). We used BODIPY-conjugated palmitate to evaluate transport of fatty acids (FAs) into mitochondria. Also, we have developed a protocol for quantification of SC-CARs, BCAA-derived metabolites. RESULTS: Using metabolic profiling, we found that BCAA starvation leads to massive triglyceride (TG) synthesis and LD accumulation. This was associated with the suppression of activated FA transport into the mitochondrial matrix. The suppression of FA import into mitochondria was rescued with the inhibitor of the acetyl-CoA carboxylase (ACC) and the activator of AMP kinase (AMPK), which both regulate carnitine palmitoyltransferase 1A (CPT1) activation status. CONCLUSIONS: Our data suggest that BCAA catabolism is required for the import of long chain carnitines (LC-CARs) into mitochondria, whereas the disruption of this link results in the redirection of activated FAs into TG synthesis and its deposition into LDs. We propose that this mechanism protects cells against mitochondrial overload with LC-CARs and it might be part of the universal reaction to amino acid perturbations during cancer growth, regulating FA handling and storage.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24005540
003      
CZ-PrNML
005      
20240729100824.0
007      
ta
008      
240405s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s40170-024-00335-5 $2 doi
035    __
$a (PubMed)38532464
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Gotvaldová, Klára $u Institute of Physiology of the Czech Academy of Sciences, Laboratory of Mitochondrial Physiology, Vídeňská 1083, 142 20, Prague 4 - Krč, Czech Republic $1 https://orcid.org/0000000207744454
245    10
$a BCAA metabolism in pancreatic cancer affects lipid balance by regulating fatty acid import into mitochondria / $c K. Gotvaldová, J. Špačková, J. Novotný, K. Baslarová, P. Ježek, L. Rossmeislová, J. Gojda, K. Smolková
520    9_
$a BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has been associated with the host dysmetabolism of branched-chain amino acids (BCAAs), however, the implications for the role of BCAA metabolism in PDAC development or progression are not clear. The mitochondrial catabolism of valine, leucine, and isoleucine is a multistep process leading to the production of short-chain R-CoA species. They can be subsequently exported from mitochondria as short-chain carnitines (SC-CARs), utilized in anabolic pathways, or released from the cells. METHODS: We examined the specificities of BCAA catabolism and cellular adaptation strategies to BCAA starvation in PDAC cells in vitro. We used metabolomics and lipidomics to quantify major metabolic changes in response to BCAA withdrawal. Using confocal microscopy and flow cytometry we quantified the fluorescence of BODIPY probe and the level of lipid droplets (LDs). We used BODIPY-conjugated palmitate to evaluate transport of fatty acids (FAs) into mitochondria. Also, we have developed a protocol for quantification of SC-CARs, BCAA-derived metabolites. RESULTS: Using metabolic profiling, we found that BCAA starvation leads to massive triglyceride (TG) synthesis and LD accumulation. This was associated with the suppression of activated FA transport into the mitochondrial matrix. The suppression of FA import into mitochondria was rescued with the inhibitor of the acetyl-CoA carboxylase (ACC) and the activator of AMP kinase (AMPK), which both regulate carnitine palmitoyltransferase 1A (CPT1) activation status. CONCLUSIONS: Our data suggest that BCAA catabolism is required for the import of long chain carnitines (LC-CARs) into mitochondria, whereas the disruption of this link results in the redirection of activated FAs into TG synthesis and its deposition into LDs. We propose that this mechanism protects cells against mitochondrial overload with LC-CARs and it might be part of the universal reaction to amino acid perturbations during cancer growth, regulating FA handling and storage.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Špačková, Jitka $u Institute of Physiology of the Czech Academy of Sciences, Laboratory of Mitochondrial Physiology, Vídeňská 1083, 142 20, Prague 4 - Krč, Czech Republic $1 https://orcid.org/0009000109305324
700    1_
$a Novotný, Jiří $u Institute of Physiology of the Czech Academy of Sciences, Laboratory of Mitochondrial Physiology, Vídeňská 1083, 142 20, Prague 4 - Krč, Czech Republic $1 https://orcid.org/0000000160455697
700    1_
$a Baslarová, Kamila $u Institute of Physiology of the Czech Academy of Sciences, Laboratory of Mitochondrial Physiology, Vídeňská 1083, 142 20, Prague 4 - Krč, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0009000424422993
700    1_
$a Ježek, Petr $u Institute of Physiology of the Czech Academy of Sciences, Laboratory of Mitochondrial Physiology, Vídeňská 1083, 142 20, Prague 4 - Krč, Czech Republic $1 https://orcid.org/0000000227209395 $7 xx0030581
700    1_
$a Rossmeislová, Lenka $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism, and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Third Faculty of Medicine, Franco-Czech Laboratory for Clinical Research on Obesity, Prague, Czech Republic $1 https://orcid.org/0000000276117585 $7 xx0095550
700    1_
$a Gojda, Jan $u Third Faculty of Medicine, Franco-Czech Laboratory for Clinical Research on Obesity, Prague, Czech Republic $u Department of Internal Medicine, Královské Vinohrady University Hospital and Third Faculty of Medicine, Prague, Czech Republic $1 https://orcid.org/0000000279955947
700    1_
$a Smolková, Katarína $u Institute of Physiology of the Czech Academy of Sciences, Laboratory of Mitochondrial Physiology, Vídeňská 1083, 142 20, Prague 4 - Krč, Czech Republic. katarina.smolkova@fgu.cas.cz $1 https://orcid.org/0000000247340200 $7 xx0139595
773    0_
$w MED00208612 $t Cancer & metabolism $x 2049-3002 $g Roč. 12, č. 1 (2024), s. 10
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38532464 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240405 $b ABA008
991    __
$a 20240729100823 $b ABA008
999    __
$a ok $b bmc $g 2075949 $s 1215302
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 12 $c 1 $d 10 $e 20240326 $i 2049-3002 $m Cancer & metabolism $n Cancer Metab $x MED00208612
GRA    __
$a NV19-01-00101 $p Agentura Pro Zdravotnický Výzkum České Republiky
GRA    __
$a NV19-01-00101 $p Agentura Pro Zdravotnický Výzkum České Republiky
GRA    __
$a NV19-01-00101 $p Agentura Pro Zdravotnický Výzkum České Republiky
LZP    __
$a Pubmed-20240405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...